{"id":"W4379649420","doi":"10.1136/annrheumdis-2023-eular.1691","title":"POS1536 ASSESSMENT OF PAIN OUTCOMES IN A PHASE 2 TRIAL OF DEUCRAVACITINIB IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS","year":2023,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Adrenal Hormones and Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Toronto","funders":"Samsung; Genentech; Servier; National Institute for Health and Care Research; Celltrion; Kiniksa Pharmaceuticals; Dutch Arthritis Association; Sun Pharma; Regeneron Pharmaceuticals; EMD Serono; University of Pennsylvania; Gilead Sciences; Sanofi; GlaxoSmithKline; Amgen; Pfizer; Celgene; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Psoriatic arthritis; Physical therapy; Arthritis; Antirheumatic Agents; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001932859,0.001061555,0.002245173,0.0002805973,0.0003142453,0.0008675419,0.0005375345,0.0008960697,0.003545939],"category_scores_gemma":[0.001298615,0.0004008496,0.001899783,0.0002960045,0.0006575775,0.0008523563,0.0002650867,0.002778654,0.0006226404],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006161181,"about_ca_system_score_gemma":0.0007905226,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005885804,"about_ca_topic_score_gemma":0.001976608,"domain_scores_codex":[0.9991585,0.0004604968,0.00006472298,0.0001172697,0.0000693725,0.0001297378],"domain_scores_gemma":[0.9991768,0.0002528113,0.0001838914,0.00006366276,0.0000665781,0.0002561759],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.867449,0.01047062,0.009342351,0.0009585621,0.003131699,0.0001615844,0.0001382058,0.002152997,0.01207774,0.0002452023,0.00225029,0.09162177],"study_design_scores_gemma":[0.5732383,0.3783194,0.03893781,0.00009344074,0.001779485,0.0004004209,0.0001218116,0.00236032,0.001975807,0.0003088066,0.002387619,0.00007683837],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9928697,0.00345142,0.0002245677,0.0004399756,0.0001804019,0.000465622,0.0005325866,0.0000508208,0.001784921],"genre_scores_gemma":[0.9962882,0.0009669809,0.0003907798,0.0004277022,0.0001142306,0.0003631773,0.0007151859,0.000008491941,0.0007253443],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003545939,"threshold_uncertainty_score":0.01186234,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02611277474082342,"score_gpt":0.3490589343388839,"score_spread":0.3229461595980605,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}